Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-28T05:24:54.519Z Has data issue: false hasContentIssue false
  • English
  • Français

Maternal lipopolysaccharide alters the newborn oxidative stress and C-reactive protein levels in response to an inflammatory stress

Published online by Cambridge University Press:  25 April 2012

Y. Ginsberg ,
P. Lotan ,
N. Khatib ,
N. Awad ,
S. Errison ,
Z. Weiner ,
N. Maravi ,
M. G. Ross ,
J. Itskovitz-Eldor  and
R. Beloosesky
Y. Ginsberg
Affiliation:
Department of Obstetrics and Gynecology, Rambam Medical Center, Haifa, Israel
P. Lotan
Affiliation:
Department of Obstetrics and Gynecology, Rambam Medical Center, Haifa, Israel
N. Khatib
Affiliation:
Department of Obstetrics and Gynecology, Rambam Medical Center, Haifa, Israel
N. Awad
Affiliation:
Department of Obstetrics and Gynecology, Rambam Medical Center, Haifa, Israel
S. Errison
Affiliation:
Department of Obstetrics and Gynecology, Rambam Medical Center, Haifa, Israel
Z. Weiner
Affiliation:
Department of Obstetrics and Gynecology, Rambam Medical Center, Haifa, Israel
N. Maravi
Affiliation:
Department of Obstetrics and Gynecology, Rambam Medical Center, Haifa, Israel
M. G. Ross
Affiliation:
Department of Obstetrics and Gynecology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA
J. Itskovitz-Eldor
Affiliation:
Department of Obstetrics and Gynecology, Rambam Medical Center, Haifa, Israel
R. Beloosesky*
Affiliation:
Department of Obstetrics and Gynecology, Rambam Medical Center, Haifa, Israel Department of Obstetrics and Gynecology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA
*
*Address for correspondence: Dr R. Beloosesky, Department of Obstetrics and Gynecology, Rambam Medical Center, Haifa, Israel. Email [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Maternal infection is associated with oxidative stress (OS) and inflammatory responses. We have previously shown that maternal exposure to lipopolysaccharide (LPS) at E18 alters the subsequent offspring immune response. As immune responses are mediated, in part, by OS, we sought to determine if maternal inflammation during pregnancy programs offspring OS and C-reactive protein (CRP) levels. Pregnant Sprague-Dawley rats received intraperitoneal (i.p.) injections of saline or LPS at 18 days’ gestation (n = 4), and pups delivered spontaneously at term. At postnatal day 24, male and female offspring received i.p. injection of LPS. Serum lipid peroxides formation (PD) and CRP levels were determined before and at 4 h following the LPS injection. Pups of LPS-exposed dams had significantly higher basal OS (PD 29.4 ± 5.4 v. 10.1 ± 4.8 nmol/ml) compared with controls. In response to LPS, CRP levels (20.4 ± 2.8 v. 5.7 ± 1.0 ng/ml) were significantly higher among pups of LPS-exposed dams than controls. Prenatal maternal exposure to LPS increases baseline OS levels in neonates and CRP levels in response to LPS. These results suggest that maternal inflammation during the antenatal period may induce long-term sequelae in the offspring that may predispose to adult disease.

Keywords

inflammationnewbornoxidative stresspregnancy
Type
Original Article
Information
Journal of Developmental Origins of Health and Disease , Volume 3 , Issue 5 , October 2012 , pp. 358 - 363
Copyright
Copyright © Cambridge University Press and the International Society for Developmental Origins of Health and Disease 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Lazzarotto, T, Lanari, M. Why is cytomegalovirus the most frequent cause of congenital infection? Expert Rev Anti Infect Ther. 2011; 9, 841–843.CrossRefGoogle ScholarPubMed
2. Gajendra, S, Kumar, JV. Oral health and pregnancy: a review. N Y State Dent J. 2004; 70, 40–44.Google ScholarPubMed
3. Hasegawa, K, Furuichi, Y, Shimotsu, A, et al. . Associations between systemic status, periodontal status, serum cytokine levels, and delivery outcomes in pregnant women with a diagnosis of threatened premature labor. J Periodontol. 2003; 74, 1764–1770.CrossRefGoogle ScholarPubMed
4. Friese, K. The role of infection in preterm labour. Br J Obstet Gynaecol. 2003; 110(Suppl. 20), 52–54.CrossRefGoogle ScholarPubMed
5. Carta, G, Persia, G, Falciglia, K, Iovenitti, P. Periodontal disease and poor obstetrical outcome. Clin Exp Obstet Gynecol. 2004; 31, 47–49.Google ScholarPubMed
6. Spinillo, A, Capuzzo, E, Stronati, M, et al. . Obstetric risk factors for periventricular leukomalacia among preterm infants. Br J Obstet Gynaecol. 1998; 105, 865–871.CrossRefGoogle ScholarPubMed
7. Blackwell, TS, Christman, JW. The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol. 1997; 17, 3–9.CrossRefGoogle ScholarPubMed
8. Leitich, H, Bodner-Adler, B, Brunbauer, M, et al. . Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol. 2003; 189, 139–147.CrossRefGoogle ScholarPubMed
9. Mednick, SA, Machon, RA, Huttunen, MO, Bonett, D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry. 1988; 45, 189–192.CrossRefGoogle Scholar
10. Ebert, T, Kotler, M. Prenatal exposure to influenza and the risk of subsequent development of schizophrenia. Isr Med Assoc J. 2005; 7, 35–38.Google ScholarPubMed
11. Brown, AS, Derkits, EJ. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry. 2010; 167, 261–280.CrossRefGoogle ScholarPubMed
12. Atladottir, HO, Thorsen, P, Ostergaard, L, et al. . Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord. 2010; 40, 1423–1430.CrossRefGoogle ScholarPubMed
13. Chess, S. Follow-up report on autism in congenital rubella. J Autism Child Schizophr. 1977; 7, 69–81.CrossRefGoogle ScholarPubMed
14. Meyer, U, Murray, PJ, Urwyler, A, et al. . Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol Psychiatry. 2008; 13, 208–221.CrossRefGoogle ScholarPubMed
15. Polivka, BJ, Nickel, JT, Wilkins, JR III. Urinary tract infection during pregnancy: a risk factor for cerebral palsy? J Obstet Gynecol Neonatal Nurs. 1997; 26, 405–413.CrossRefGoogle ScholarPubMed
16. Murphy, DJ, Sellers, S, MacKenzie, IZ, Yudkin, PL, Johnson, AM. Case–control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet. 1995; 346, 1449–1454.CrossRefGoogle ScholarPubMed
17. Yoon, BH, Jun, JK, Romero, R, et al. . Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol. 1997; 177, 19–26.CrossRefGoogle ScholarPubMed
18. Beloosesky, R, Weiner, Z, Khativ, N, et al. . Prophylactic maternal N-acetylcysteine before lipopolysaccharide suppresses fetal inflammatory cytokine responses. Am J Obstet Gynecol. 2009; 200, 665, e1-5.CrossRefGoogle ScholarPubMed
19. Morein, B, Blomqvist, G, Hu, K. Immune responsiveness in the neonatal period. J Comp Pathol. 2007; 137(Suppl. 1), S27–S31.CrossRefGoogle ScholarPubMed
20. Philbin, VJ, Levy, O. Developmental biology of the innate immune response: implications for neonatal and infant vaccine development. Pediatr Res. 2009; 65(5Pt 2), 98R–105R.CrossRefGoogle ScholarPubMed
21. Immunobiology. The Immune System in Health and Disease, 5th edn, 2001. Garland Science: New York, NY.Google Scholar
22. Drake, AJ, Walker, BR, Seckl, JR. Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats. Am J Physiol Regul Integr Comp Physiol. 2005; 288, R34–R38.CrossRefGoogle ScholarPubMed
23. Beloosesky, R, Maravi, N, Weiner, Z, et al. . Maternal lipopolysaccharide-induced inflammation during pregnancy programs impaired offspring innate immune responses. Am J Obstet Gynecol. 2010; 203, 185e1–4.CrossRefGoogle ScholarPubMed
24. Beloosesky, R, Gayle, DA, Ross, MG. Maternal N-acetylcysteine suppresses fetal inflammatory cytokine responses to maternal lipopolysaccharide. Am J Obstet Gynecol. 2006; 195, 1053–1057.CrossRefGoogle ScholarPubMed
25. Awad, N, Khatib, N, Ginsberg, Y, et al. . N-acetyl-cysteine (NAC) attenuates LPS-induced maternal and amniotic fluid oxidative stress and inflammatory responses in the preterm gestation. Am J Obstet Gynecol. 2011; 204, 450e15–20.CrossRefGoogle ScholarPubMed
26. Aviram, M, Vaya, J. Markers for low-density lipoprotein oxidation. Methods Enzymol. 2001; 335, 244–256.CrossRefGoogle ScholarPubMed
27. el-Saadani, M, Esterbauer, H, el-Sayed, M, et al. . A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res. 1989; 30, 627–630.CrossRefGoogle ScholarPubMed
28. Xu, DX, Wang, H, Zhao, L, et al. . Effects of low-dose lipopolysaccharide (LPS) pretreatment on LPS-induced intra-uterine fetal death and preterm labor. Toxicology. 2007; 234, 167–175.CrossRefGoogle ScholarPubMed
29. Chen, YH, Wang, JP, Wang, H, et al. . Lipopolysaccharide treatment downregulates the expression of the pregnane X receptor, cyp3a11 and mdr1a genes in mouse placenta. Toxicology. 2005; 211, 242–252.CrossRefGoogle ScholarPubMed
30. Ejima, K, Koji, T, Tsuruta, D, et al. . Induction of apoptosis in placentas of pregnant mice exposed to lipopolysaccharides: possible involvement of Fas/Fas ligand system. Biol Reprod. 2000; 62, 178–185.CrossRefGoogle ScholarPubMed
31. Paintlia, MK, Paintlia, AS, Barbosa, E, Singh, I, Singh, AK. N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain. J Neurosci Res. 2004; 78, 347–361.CrossRefGoogle ScholarPubMed
32. Paintlia, MK, Paintlia, AS, Contreras, MA, Singh, I, Singh, AK. Lipopolysaccharide-induced peroxisomal dysfunction exacerbates cerebral white matter injury: attenuation by N-acetyl cysteine. Exp Neurol. 2008; 210, 560–576.CrossRefGoogle ScholarPubMed
33. Lante, F, Meunier, J, Guiramand, J, et al. . Neurodevelopmental damage after prenatal infection: role of oxidative stress in the fetal brain. Free Radic Biol Med. 2007; 42, 1231–1245.CrossRefGoogle ScholarPubMed
34. Lante, F, Meunier, J, Guiramand, J, et al. . Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation. Hippocampus. 2008; 18, 602–609.CrossRefGoogle Scholar
35. Fowden, AL, Giussani, DA, Forhead, AJ. Intrauterine programming of physiological systems: causes and consequences. Physiology (Bethesda). 2006; 21, 29–37.Google ScholarPubMed
36. Aviram, M. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radic Res. 2000; (Suppl. 33), S85–S97.Google ScholarPubMed
37. Ross, R. Atherosclerosis – an inflammatory disease. N Engl J Med. 1999; 340, 115–126.CrossRefGoogle ScholarPubMed
38. Ridker, PM, Cushman, M, Stampfer, MJ, Tracy, RP, Hennekens, CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998; 97, 425–428.CrossRefGoogle ScholarPubMed
39. Ridker, PM, Glynn, RJ, Hennekens, CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 1998; 97, 2007–2011.CrossRefGoogle Scholar
40. Kuller, LH, Tracy, RP, Shaten, J, Meilahn, EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case–control study. Multiple risk factor intervention trial. Am J Epidemiol. 1996; 144, 537–547.Google ScholarPubMed
41. Tracy, RP, Lemaitre, RN, Psaty, BM, et al. . Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the cardiovascular health study and the rural health promotion project. Arterioscler Thromb Vasc Biol. 1997; 17, 1121–1127.CrossRefGoogle ScholarPubMed
42. Liuzzo, G, Biasucci, LM, Gallimore, JR, et al. . The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med. 1994; 331, 417–424.CrossRefGoogle ScholarPubMed
43. Dempsey, PW, Vaidya, SA, Cheng, G. The art of war: innate and adaptive immune responses. Cell Mol Life Sci. 2003; 60, 2604–2621.CrossRefGoogle ScholarPubMed
44. Sun, H, Koike, T, Ichikawa, T, et al. . C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance. Am J Pathol. 2005; 167, 1139–1148.CrossRefGoogle ScholarPubMed
45. Kushner, I, Jiang, SL, Zhang, D, Lozanski, G, Samols, D. Do post-transcriptional mechanisms participate in induction of C-reactive protein and serum amyloid A by IL-6 and IL-1? Ann N Y Acad Sci. 1995; 762, 102–107.CrossRefGoogle ScholarPubMed
46. Escobar-Morreale, HF, Luque-Ramirez, M, Gonzalez, F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril. 2011; 95, 1048–1058.CrossRefGoogle ScholarPubMed
47. Wilson, AM, Ryan, MC, Boyle, AJ. The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Int J Cardiol. 2006; 106, 291–297.CrossRefGoogle ScholarPubMed
48. Valko, M, Leibfritz, D, Moncol, J, et al. . Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007; 39, 44–84.CrossRefGoogle ScholarPubMed
49. Kushner, I, Rzewnicki, D, Samols, D. What does minor elevation of C-reactive protein signify? Am J Med. 2006; 119, 166e17–28.CrossRefGoogle ScholarPubMed
50. Kirsten, TB, de Oliveira, BP, de Oliveira, AP, et al. . Single early prenatal lipopolysaccharide exposure prevents subsequent airway inflammation response in an experimental model of asthma. Life Sci. 2011; 89, 15–19.CrossRefGoogle Scholar
51. Desai, M, Gayle, DA, Casillas, E, Boles, J, Ross, MG. Early undernutrition attenuates the inflammatory response in adult rat offspring. J Matern Fetal Neonatal Med. 2009; 22, 571–575.CrossRefGoogle ScholarPubMed